Evaluation of a functional index for patients with ankylosing spondylitis. - Suppr | 超能文献

Evaluation of a functional index for patients with ankylosing spondylitis.

作者信息

Dougados M, Gueguen A, Nakache J P, Nguyen M, Amor B

出版信息

J Rheumatol. 1990 Sep;17(9):1254-5.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Evaluation of a functional index for patients with ankylosing spondylitis.

J Rheumatol. 1990 Sep;17(9):1254-5.

2

[Ankylosing spondylitis].[强直性脊柱炎]

Rev Prat. 2001 Nov 1;51(17):1961-7.

3

Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.在无临床明显心血管疾病的强直性脊柱炎患者中，动脉僵硬度增加或内膜中层厚度增加的趋势。

Rheumatology (Oxford). 2008 Aug;47(8):1203-7. doi: 10.1093/rheumatology/ken198. Epub 2008 Jun 4.

4

Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.巴斯强直性脊柱炎疾病活动指数与该指数的一个修订版本在评估无外周表现的强直性脊柱炎患者疾病活动度方面的比较。

Ann Rheum Dis. 2009 Nov;68(11):1701-7. doi: 10.1136/ard.2008.099226. Epub 2008 Nov 24.

5

Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis.强直性脊柱炎结局标准中患者可接受症状状态随时间的稳定性。

Arthritis Rheum. 2006 Dec 15;55(6):960-3. doi: 10.1002/art.22342.

6

Intraarticular injection of infliximab.英夫利昔单抗关节腔内注射。

J Rheumatol. 2006 Sep;33(9):1912-3; author reply 1913.

7

Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity.强直性脊柱炎的结局变量：对其相关性和判别能力的评估。

J Rheumatol. 1999 Apr;26(4):975-9.

8

Ankylosing spondylitis in Singaporean Chinese--a clinical profile.

Singapore Med J. 1993 Dec;34(6):518-20.

9

Assessment of fatigue in the management of patients with ankylosing spondylitis.强直性脊柱炎患者管理中疲劳的评估

Rheumatology (Oxford). 2003 Dec;42(12):1523-8. doi: 10.1093/rheumatology/keg421. Epub 2003 Sep 16.

10

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.静脉注射帕米膦酸二钠（60毫克与10毫克）治疗非甾体抗炎药难治性强直性脊柱炎的六个月随机、对照、双盲、剂量反应比较。

Arthritis Rheum. 2002 Mar;46(3):766-73. doi: 10.1002/art.10139.

引用本文的文献

1

Clinical Tools to Assess and Monitor Spondyloarthritis.评估和监测脊柱关节炎的临床工具

Curr Rheumatol Rep. 2015 Jul;17(7):47. doi: 10.1007/s11926-015-0522-3.

2

The reliability and validity of a Korean translation of the ASAS Health Index and Environmental Factors in Korean patients with axial spondyloarthritis.韩国轴向脊柱关节炎患者中ASAS健康指数韩语翻译版及环境因素的可靠性和有效性。

J Korean Med Sci. 2014 Mar;29(3):334-7. doi: 10.3346/jkms.2014.29.3.334. Epub 2014 Feb 27.

3

Therapeutic effects of individual physical therapy in ankylosing spondylitis related to duration of disease.

Clin Rheumatol. 1993 Sep;12(3):334-40. doi: 10.1007/BF02231574.

4

Factors related to change in global health after group physical therapy in ankylosing spondylitis.强直性脊柱炎患者进行团体物理治疗后全球健康状况变化的相关因素。

Clin Rheumatol. 1995 May;14(3):347-51. doi: 10.1007/BF02208352.